Laura E Via Selected Research

Laura E Via Research Topics

Disease

48	Tuberculosis (Tuberculoses) 04/2024 - 06/2008
18	Infections 04/2024 - 06/2008
15	Granuloma 04/2024 - 06/2008
12	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 01/2010
8	Extensively Drug-Resistant Tuberculosis 01/2017 - 01/2008
5	Inflammation (Inflammations) 09/2022 - 01/2018
5	Pulmonary Tuberculosis 01/2021 - 10/2012
3	Hypoxia (Hypoxemia) 02/2024 - 02/2015
2	Atherosclerosis 03/2024 - 01/2018
2	Necrosis 02/2024 - 04/2016
2	Paramyxoviridae Infections (Parainfluenza) 12/2022 - 05/2022
2	COVID-19 10/2022 - 09/2022
2	Pneumonia (Pneumonitis) 10/2022 - 09/2022
2	Lung Diseases (Lung Disease) 01/2022 - 07/2015
2	Persistent Infection 01/2021 - 08/2012
2	Disease Progression 10/2019 - 07/2014
1	Fibrosis (Cirrhosis) 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Ototoxicity 01/2021
1	Extrapulmonary Tuberculosis 11/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Latent Tuberculosis 05/2015
1	Gout 05/2015
1	Neoplasms (Cancer) 02/2015

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2014
7	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 01/2012
7	FluoroquinolonesIBA 01/2017 - 01/2008
6	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 08/2011
5	LipidsIBA 03/2024 - 01/2012
5	Kanamycin FDA Link 01/2021 - 01/2008
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2012
5	Pyrazinamide FDA LinkGeneric 01/2018 - 01/2012
4	VaccinesIBA 12/2022 - 07/2014
4	AntigensIBA 10/2022 - 06/2008
4	CytokinesIBA 09/2022 - 11/2012
4	Amikacin (A.M.K)FDA LinkGeneric 01/2021 - 02/2010
4	Streptomycin (Streptomycin Sulfate)FDA Link 01/2021 - 01/2008
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2013
4	EnzymesIBA 10/2019 - 07/2013
4	Linezolid (Zyvox)FDA Link 11/2015 - 06/2012
3	Oxygen (Dioxygen)IBA 02/2024 - 06/2008
3	AminoglycosidesIBA 01/2021 - 02/2010
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2020 - 07/2015
3	Messenger RNA (mRNA)IBA 12/2017 - 10/2016
3	Moxifloxacin (Avelox)FDA Link 01/2017 - 03/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2012
2	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2017
2	Antimicrobial PeptidesIBA 04/2024 - 01/2016
2	Bevacizumab (Avastin)FDA Link 04/2024 - 02/2015
2	COVID-19 VaccinesIBA 12/2022 - 05/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2010
2	EicosanoidsIBA 01/2016 - 07/2014
1	Losartan (Cozaar)FDA LinkGeneric 04/2024
1	cholesterol 25-hydroxylaseIBA 03/2024
1	CollagenIBA 01/2023
1	Coloring Agents (Dyes)IBA 01/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2023
1	Viral RNAIBA 10/2022
1	InterferonsIBA 10/2022
1	Neutralizing AntibodiesIBA 09/2022
1	Interleukin-10 (Interleukin 10)IBA 09/2022
1	IgA receptor (protein B)IBA 05/2022
1	MacrolidesIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Caspase 1 (ICE Protease)IBA 01/2021
1	5- (2- oxopropylideneamino)- 6- d- ribitylaminouracilIBA 01/2021
1	Inflammation MediatorsIBA 11/2019
1	CytochromesIBA 10/2019
1	Oxidoreductases (Dehydrogenase)IBA 10/2019
1	AmidesIBA 10/2019
1	MagnesiumIBA 11/2018
1	ElementsIBA 11/2018
1	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2018
1	CholesterolIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	GuanineIBA 01/2017
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2017
1	SolutionsIBA 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	ProteomeIBA 01/2016
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2015
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 11/2015
1	LipopolysaccharidesIBA 08/2015
1	Granzymes (Granzyme)IBA 08/2015
1	PerforinIBA 08/2015
1	Aligeron (AS 2)IBA 07/2015
1	bedaquiline (R207910)IBA 06/2015
1	Allopurinol (Remid)FDA LinkGeneric 05/2015
1	Xanthine OxidaseIBA 05/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015

Therapy/Procedure

14	Therapeutics 04/2024 - 01/2008
8	Drug Therapy (Chemotherapy) 04/2024 - 01/2010
4	Injections 01/2021 - 10/2012
3	Duration of Therapy 01/2022 - 01/2008
2	Aftercare (After-Treatment) 01/2016 - 12/2014
2	Lasers (Laser) 01/2016 - 10/2015
1	Secondary Prevention 01/2023